UY32197A - Sinergismo antibiotico - Google Patents

Sinergismo antibiotico

Info

Publication number
UY32197A
UY32197A UY0001032197A UY32197A UY32197A UY 32197 A UY32197 A UY 32197A UY 0001032197 A UY0001032197 A UY 0001032197A UY 32197 A UY32197 A UY 32197A UY 32197 A UY32197 A UY 32197A
Authority
UY
Uruguay
Prior art keywords
antibiotic
synergism
antibiotic synergism
defensin
beta
Prior art date
Application number
UY0001032197A
Other languages
English (en)
Inventor
Hoegenhaug Hans-Henrik Kristensen
Sandvang Dorthe
Mygind Per Holse
Thomas Kruse
Nielsen Line Anker
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of UY32197A publication Critical patent/UY32197A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al sinergismo antibiótico de composiciones farmacéuticas que comprenden una defensina y un antibiótico betalactámico.
UY0001032197A 2008-10-24 2009-10-23 Sinergismo antibiotico UY32197A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08167489 2008-10-24
EP09156992 2009-03-31

Publications (1)

Publication Number Publication Date
UY32197A true UY32197A (es) 2010-05-31

Family

ID=41849325

Family Applications (2)

Application Number Title Priority Date Filing Date
UY0001032198A UY32198A (es) 2008-10-24 2009-10-23 Tratamiento de infecciones bacterianas intracelulares
UY0001032197A UY32197A (es) 2008-10-24 2009-10-23 Sinergismo antibiotico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY0001032198A UY32198A (es) 2008-10-24 2009-10-23 Tratamiento de infecciones bacterianas intracelulares

Country Status (8)

Country Link
US (1) US20100105602A1 (es)
EP (1) EP2349317A2 (es)
CN (1) CN102264383A (es)
AR (1) AR074059A1 (es)
PA (1) PA8846601A1 (es)
TW (1) TW201019954A (es)
UY (2) UY32198A (es)
WO (1) WO2010046461A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006256791B2 (en) * 2005-06-06 2012-01-19 Novozymes Adenium Biotech A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
KR101667278B1 (ko) * 2015-08-14 2016-10-18 군산대학교 산학협력단 미국산 굴에서 유래한 항균 펩타이드 및 이를 함유하는 항균용 약학 조성물
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006256791B2 (en) * 2005-06-06 2012-01-19 Novozymes Adenium Biotech A/S Polypeptides having antimicrobial activity and polynucleotides encoding same

Also Published As

Publication number Publication date
WO2010046461A3 (en) 2010-07-01
AR074059A1 (es) 2010-12-22
EP2349317A2 (en) 2011-08-03
PA8846601A1 (es) 2010-05-26
WO2010046461A2 (en) 2010-04-29
CN102264383A (zh) 2011-11-30
UY32198A (es) 2010-05-31
US20100105602A1 (en) 2010-04-29
TW201019954A (en) 2010-06-01

Similar Documents

Publication Publication Date Title
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
ES2571041T3 (es) Composiciones antimicrobianas
CL2008003405A1 (es) Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih.
UA106748C2 (uk) Похідні проліну як інгібітори катепсину
MX2010014041A (es) Una forma cristalina de posaconazol.
GT201200276A (es) Combinaciones de compuestos activos
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
CU20100230A7 (es) Composición farmacéutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
BR112013007362A2 (pt) composição farmacêutica
PA8827101A1 (es) Derivados de indazoles sustituidos con fenilo o piridinilo
MX2012003185A (es) Composiciones farmaceuticas que comprenden bi-1356 y metformina.
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MY153116A (en) Smac mimetic
CL2007003565A1 (es) Compuestos derivados de piperidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion vih.
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
UY33754A (es) Monobactamas
PA8846401A1 (es) Sinergismo antibiótico
GT201200284A (es) Composición farmacéutica
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MX2010002734A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
BRPI0914971A2 (pt) composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
BRPI1009375A2 (pt) derivados inibidores de hsp90, composições que os contém e utilização
BRPI0909211A2 (pt) formulação orais e injetáveis de composto de tetraciclina

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20130125